BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for ... Earthtimes, UK - ... announced today that it has initiated a Phase 2a clinical trial with its lead product candidate, BCI-540, for the treatment of depression with anxiety. ... |
Friday, April 18, 2008
BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for ... - Earthtimes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment